Biofunctional peptides are specific protein fragments that have a positive impact on body functions and conditions and may ultimately influence health peptides modulate physiological function through binding interactions to specific receptors on target cells leading to the induction of physiological responses. Biofunctional peptides are generally 3-20 amino acids residues in length containing potential bioactive sequences from animal and plant source. The most common method of production for Biofunctional peptides is enzymatic hydrolysis. Multiple Biofunctional peptides are produced using trypsin or pepsin. These Biofunctional peptides play an important role in the regulation of the digestive system, immune system, cardiovascular, nervous system and modulation of nutrient absorption. Currently, the market products of Biofunctional peptides contain peptides with satiety including anti-cancer, antimicrobial, stress-relieving properties and others. Biofunctional peptides possess a scientific challenge as they are known to cause optimal exploitation for health benefits. At the same time Biofunctional peptides offer various commercial benefits, owing to which the market of Biofunctional peptides is anticipated to have rapid growth with exceptional CAGR over the forecast period.
Planning to lay down future strategy? Perfect your plan with our report brochure here
Development of Novel Biofunctional Peptides Would Stimulate New Drug Development in Peptide Therapeutics
The synthesis of Biofunctional peptides highly influences the production of multiple antibodies. These peptides are also useful in inventing unique techniques for drug discovery and development and biological research. Various companies and organization store and maintain the peptide library which will help in future to develop various types of vaccines, drugs, amino acid sequencing for research purpose. The rising demand for research and development for early detection and diagnosis of various diseases such as metabolic disorder, cardiovascular disorders, and various genetic disorders. The treatments involving gene therapy can be abundantly supported by developing target specific Biofunctional peptides. Along with increasing healthcare expenditure and an increasing number of clinical trials using Biofunctional peptides are boosting the Biofunctional market globally.
Development of novel technologies, more pieces of evidence of safety and increased knowledge regarding the mechanism and function of peptides will support the growth of the market. Due to the rising demand for potential health benefits, globally the market of Biofunctional peptides is expected to have burgeoning growth. Due to a wide range of applications of Biofunctional peptides, the manufacturers are incorporating peptides as ingredients in the food and dietary supplement. The demand for Biofunctional peptides is expected to grow among the manufacturers of cosmetics and personal care products. Owing to the supportive infrastructure, high acceptance for Biofunctional peptides and rising research activities due to increasing demand is boosting North America to grow as a leader in the Biofunctional peptides market over the globe.
Want to know the obstructions to your company’s growth in future? Request a Custom report here
Biofunctional Peptides Market Segmentation
On the basis of source, the biofunctional peptides market has been segmented as-
On the basis of processing method, the biofunctional peptides market has been segmented as-
- Enzymatic Hydrolysis
- Microbial Fermentation
- Recombinant DNA
- Chemical Synthesis
On the basis of therapeutic area, the biofunctional peptides market has been segmented as-
- Cardiovascular System
- Nervous System
- Gastrointestinal System
- Immune System
- Anti-Diabetic Peptides
- Multifunctional Peptides
On the basis of distribution channel, the biofunctional peptides market has been segmented as-
- Drug Store
- Specialty Store
- Mail Order Pharmacy
- Hospital Pharmacy
- Others (Online Store etc.)
Biofunctional Peptides Market: Key Players
Merck KGaA, Seagarden AS, WN Pharmaceuticals Ltd., Arlak Biotech Pvt. Ltd., Phermpep Co. Ltd., Ashland Inc., ALEXIS Corporation, American Peptide Company Inc., Promega Corporation, Advanced Bioconcept Company, Anaspec Inc. Thermo Fisher Scientific, Novo Nordisk A/S and others.
In 2017, few numbers of new peptide received approval from UDFDA including TRULANCE (Synergy Pharmaceuticals), OZEMPIC (Novo Nordisk), TYMLOS (Radius Health), Parsabiv (Amgen).
Biofunctional Peptides Market Opportunities
The rising cost of research and development in pharmaceutical with a decline in the number of approved drugs has created a demand for an alternative approach to accelerate the R&D activities. To have a profitable market in the highly competitive market, the companies are identifying the opportunity of developing a new drug and new therapies for the treatment of multiple disease and disorders. The Biofunctional peptides are emerging as a unique class of drugs and thus becoming an important part of the pipeline for the biopharmaceutical, pharmaceutical and other industries. The limited production capacity of peptides with specific targets have become a challenge for the industry.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.